Financial statements Wd Pharma
Balance sheet of Wd Pharma
Company age:
Age:
13 y. 11 m. 1 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of WD PHARMA
|
Year
|
2020
|
2021
|
|---|---|---|
| Total assets | 28 048 789,51 | 28 778 120,42 |
| A. Fixed assets | 28 046 708,51 | 28 775 349,42 |
| B. Current assets | 2 081,00 | 2 771,00 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 28 048 789,51 | 28 778 120,42 |
| A. Equity | 4 097 444,24 | 4 138 065,69 |
| B. Liabilities and provisions for liabilities | 23 951 345,27 | 24 640 054,73 |
| I. Long-term liabilities | 23 950 471,84 | 24 639 956,30 |
| II. Short-term liabilities | 873,43 | 98,43 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.